- A company modifies a stock option award by reducing the exercise price (a repricing). Under ASC 718, what is the accounting treatment for the modification?
Answer: Incremental compensation cost is recognized, equal to the excess of the modified award's fair value over the original award's fair value on the modification date.
Under ASC 718, a modification is accounted for by comparing the fair value of the modified award to the fair value of the original award immediately before modification. Any excess (incremental fair value) is recognized as additional compensation cost over the remaining requisite service period. Previously recognized compensation is not reversed. Answer A is correct. Answer B reverses prior expense and starts over, which overstates cost. Answer C ignores the incremental fair value from the repricing. Answer D records a company loss, treating an equity transaction as an income statement item.
- A company grants 6,000 options on January 1, Year 1 with a grant-date fair value of $15 each, vesting cliff at the end of Year 3. At the end of Year 2, 500 options are forfeited. Accounting for forfeitures as they occur, what is the cumulative compensation expense through December 31, Year 2?
Answer: $55,000
Year 1 expense (all 6,000 options): 6,000 x $15 / 3 = $30,000. At end of Year 2, 500 options forfeited: reverse Year 1 expense for those options: 500 x $15 / 3 = $2,500. Year 2 expense for remaining 5,500 options: 5,500 x $15 / 3 = $27,500. Net Year 2 expense = $27,500 - $2,500 = $25,000. Cumulative through Year 2 = $30,000 + $25,000 = $55,000. Alternatively: 5,500 options x $15 x (2/3) = $55,000. Answer C is correct. Answer A ignores forfeitures entirely. Answer B subtracts only one year of forfeited expense. Answer D recognizes only Year 2 expense.
- A company grants performance-based restricted stock units that vest only if the company achieves a specific earnings target. The target is considered probable of achievement. How should compensation expense be recognized?
Answer: Recognized over the service period based on the probability-weighted outcome, adjusted as probability assessments change.
Under ASC 718, compensation cost for performance-based awards is recognized over the requisite service period based on the probable outcome of the performance condition. If achievement is probable, expense accrues over the service period. If the probability assessment changes, the cumulative expense is adjusted in the period of change. Answer D is correct. Answer A defers all recognition until the target is confirmed, ignoring accrual accounting. Answer B recognizes immediately at grant regardless of service. Answer C is an all-or-nothing approach that does not reflect the probability-based model required by ASC 718.
- Under ASC 718, which of the following types of awards is most likely to be classified as a liability rather than equity?
Answer: Stock appreciation rights that require cash settlement.
Under ASC 718, an award is classified as a liability if the entity is obligated to transfer cash or other assets to the employee. Cash-settled SARs require cash settlement, making them liability awards remeasured at fair value each period. Answer A is correct. RSUs settled in shares (B), stock options settled in shares (C), and performance shares settled in stock (D) are all equity-classified awards because settlement occurs in the company's own equity instruments rather than cash.
- What amount should Epsilon record as compensation expense for the year ended December 31, 2024?
Answer: $1,875
SARs are liability-classified awards measured at fair value each reporting period. The intrinsic value at December 31, 2024 = ($35 - $30) × 1,000 = $5,000. However, since the SARs vest ratably over 2 years and were granted on October 1, 2024, only 3 months of the first year have passed. The portion vested by December 31, 2024 = 3/24 months = 12.5%. Compensation expense = $5,000 × 12.5% = $625. This doesn't match any answer choice. Let me reconsider: if we use the expected final value ($45), the total expected compensation = ($45 - $30) × 1,000 = $15,000. The annual expense = $15,000 ÷ 2 years = $7,500. For 3 months (Oct-Dec 2024) = $7,500 × 3/12 = $1,875. Choice C is correct. Choice A ($1,250) might represent using current intrinsic value with different timing. Choice B ($3,750) is half the annual expected expense. Choice D ($2,500) might represent an incorrect calculation using current intrinsic value over 2 years.
- When stock options expire unexercised after vesting, what is the correct accounting treatment under ASC 718?
Answer: No adjustment to compensation expense; the APIC balance from the options remains in equity.
When vested options expire unexercised, compensation expense is not reversed - the employee rendered the service and the compensation has been appropriately recognized. The APIC-Stock Options balance associated with the expired options remains in stockholders' equity; it is typically reclassified from APIC-Stock Options to APIC-Other or left as is. No income statement impact occurs. Answer D is correct. Answer A reverses expense after vesting, which is not permitted. Answer B records a gain, treating an equity transaction as income. Answer C reduces APIC without increasing Retained Earnings - the entire APIC balance is retained in equity.
- Which of the following correctly describes the accounting for stock-based compensation awards granted to nonemployees under ASC 718 (as amended by ASU 2018-07)?
Answer: Nonemployee awards are measured at grant-date fair value, consistent with employee award accounting.
ASU 2018-07 aligned the accounting for nonemployee share-based payment awards with employee award accounting. Nonemployee equity-classified awards are now measured at grant-date fair value and recognized over the service period, consistent with employee awards. Answer A is correct. Answer B describes the pre-ASU 2018-07 treatment, which required remeasurement through vesting. Answer C uses intrinsic value, which is inconsistent with ASC 718's fair value model. Answer D is incorrect; nonemployee awards follow the same equity vs. liability classification principles as employee awards.
- An employee is granted options that vest immediately (no service period required). How should compensation expense be recognized under ASC 718?
Answer: Entirely on the grant date, since there is no future service requirement.
Under ASC 718, the requisite service period is the period over which the employee must provide service to earn the award. If an award vests immediately with no service requirement, the entire compensation cost is recognized on the grant date because the employee has no future obligation to provide services in exchange for the award. Answer C is correct. Answer A assumes a future service period that does not exist. Answer B applies an arbitrary one-year convention with no basis in ASC 718. Answer D delays recognition until exercise, which is inconsistent with the grant-date measurement model.
- A company grants stock options with a 4-year cliff vesting schedule. At the end of Year 3, the company determines that it is no longer probable that the employees will complete the required service period. What is the cumulative effect on compensation expense through Year 3?
Answer: All previously recognized compensation expense is reversed to zero in the period the service condition is determined to be no longer probable of being met.
Under ASC 718, when it is determined that a service condition will not be met, all previously recognized compensation expense for that award is reversed in the period of that determination. The cumulative compensation cost is reduced to zero because no benefit is ultimately received - the employee will not vest. Answer D is correct. Answer A recognizes three-quarters of the cost as if partial vesting occurs, but cliff-vesting awards confer no partial benefit if the employee leaves before the vesting date. Answer B correctly arrives at zero cumulative expense but implies expense was never appropriately recognized in prior periods, which is incorrect - prior recognition was appropriate and is reversed in the current period. Answer C ignores the required reassessment and continues expense accrual despite the changed probability determination.
- Kappa Inc. granted cash-settled stock appreciation rights (SARs) with the following terms: 5,000 SARs granted on January 1, 2024, with a $25 base price and three-year cliff vesting. The stock prices were $30 on December 31, 2024, and $35 on December 31, 2025. What is the compensation expense Kappa should recognize for 2025?
Answer: $25,000
Cash-settled SARs are liability awards remeasured at each reporting date. At December 31, 2024, the liability was ($30 - $25) × 5,000 × 1/3 = $8,333 (representing 1 year of 3-year cliff vesting). At December 31, 2025, the liability should be ($35 - $25) × 5,000 × 2/3 = $33,333 (representing 2 years of 3-year cliff vesting). Therefore, 2025 compensation expense = $33,333 - $8,333 = $25,000.
- When an employee exercises vested stock options, which of the following correctly describes the accounting entry under ASC 718?
Answer: Cash is debited, Additional Paid-In Capital - Stock Options is reclassified to Common Stock and APIC, and no additional compensation expense is recorded.
When stock options are exercised, the company receives the exercise price (debit Cash), removes the balance in APIC-Stock Options (debit APIC-Stock Options), and credits Common Stock at par and APIC for the total consideration. No additional compensation expense is recognized at exercise - all expense was recognized over the vesting period. Answer B is correct. Answer A records compensation at exercise date, which violates ASC 718's grant-date measurement principle. Answer C records a gain, but option exercises are equity transactions with no income statement effect on the issuer. Answer D credits Retained Earnings, which is incorrect.
- A company has recognized $200,000 of cumulative compensation expense for a stock option award over the vesting period. When the employees exercise their options, the total tax deduction allowed is $240,000. Using a 21% tax rate, how is the total income tax effect at exercise recognized under ASU 2016-09?
Answer: $50,400 tax benefit recognized in income tax expense; excess benefit of $8,400 flows through the income statement.
At exercise, the actual tax deduction ($240,000 x 21% = $50,400) exceeds the deferred tax asset previously established for cumulative book compensation expense ($200,000 x 21% = $42,000). Under ASU 2016-09, the full $50,400 tax benefit is recognized at exercise: the $42,000 reversal of the deferred tax asset, plus the $8,400 excess tax benefit (windfall) recognized immediately in income tax expense in the income statement. Answer B is correct. Answer A credits the excess $8,400 to APIC, which was the pre-ASU 2016-09 treatment and is no longer permitted. Answer C defers the excess until expiration or forfeiture, which is inconsistent with ASU 2016-09's requirement to recognize windfalls immediately in the income statement. Answer D defers the excess until vesting, but vesting has already occurred at the point of exercise.
- Under ASC 718, which of the following is included in the grant-date fair value measurement of a stock option?
Answer: Both the intrinsic value component and the time value component of the option.
The fair value of a stock option has two components: intrinsic value (excess of current market price over exercise price) and time value (the value of the right to wait before exercising). Grant-date fair value as measured by option pricing models captures both components. Answer B is correct. Answer A uses only expected intrinsic value at exercise, ignoring time value. Answer C includes only time value, ignoring intrinsic value. Answer D introduces book value, which is not an option pricing concept.
- What amount should Alpha record as stock-based compensation expense for the year ended December 31, 2024?
Answer: $60,000
For performance-based awards, compensation expense is based on the probable outcome. Initially, expected shares to vest = 8,000 × 70% = 5,600 shares. Total expected compensation = 5,600 × $25 = $140,000 over 3 years. By December 31, 2024, the probability increased to 90%, so expected shares = 8,000 × 90% = 7,200 shares. Revised total compensation = 7,200 × $25 = $180,000. The cumulative expense through December 31, 2024 (end of year 1) should be $180,000 × 1/3 = $60,000. Since this is the first year, the 2024 expense equals the cumulative expense of $60,000. Choice A ($46,667) would be 1/3 of the original estimate ($140,000 ÷ 3). Choice C ($50,000) doesn't correspond to any logical calculation. Choice D ($66,667) might represent an incorrect calculation mixing the probabilities.
- Under ASC 718, which of the following correctly describes the treatment of tax benefits related to stock-based compensation?
Answer: Excess tax benefits (windfalls) are recognized in income tax expense within the income statement.
Under ASU 2016-09 (now codified in ASC 718), all excess tax benefits and tax deficiencies related to stock-based compensation are recognized in income tax expense in the income statement. This includes both windfalls (when the tax deduction exceeds book expense) and shortfalls (when the deduction is less than book expense). Answer B is correct. Answer A nets tax benefits against compensation expense rather than recording them in the tax provision. Answer C was the pre-ASU 2016-09 treatment for deficiencies. Answer D defers all tax effects, which is inconsistent with ASC 718 and ASC 740.
- Assuming a 25% tax rate, what is the total tax effect Mu should recognize in 2024 related to these stock options?
Answer: $3,333 tax benefit
The tax effect has two components: (1) deferred tax asset for cumulative compensation expense and (2) current tax benefit for exercises. Cumulative compensation expense through 2024 = 10,000 options × $4 × 1/3 = $13,333. This creates a deferred tax asset of $13,333 × 25% = $3,333. For the exercised options, since the tax deduction is limited to grant-date fair value ($4 per option), the current tax benefit = 3,000 × $4 × 25% = $3,000. However, this benefit reduces the deferred tax asset, so the net effect is just the deferred tax asset of $3,333. Choice A ($5,250) might represent the tax benefit on the full intrinsic value (3,000 × $7 × 25%). Choice B ($3,000) represents only the current tax benefit without considering the deferred tax asset. Choice C ($8,583) doesn't correspond to a logical calculation for this scenario.
- A company grants restricted stock units (RSUs) to an employee. The RSUs vest after 3 years of service and will be settled in shares. How should the compensation cost be recognized?
Answer: Recognized ratably over the 3-year service period based on grant-date fair value.
Under ASC 718, RSUs are equity-classified awards measured at grant-date fair value and expensed over the requisite service period (the vesting period). For cliff-vesting RSUs, the expense is recognized on a straight-line basis over the 3-year service period. Answer D is correct. Answer A uses the vesting date fair value and delays recognition. Answer B recognizes everything immediately at grant. Answer C delays recognition until delivery, which is after the service has been performed.
- Under ASC 718, stock options granted to employees are measured at which value on which date?
Answer: Fair value on the grant date.
Under ASC 718, equity-classified employee stock options are measured at fair value on the grant date. This amount is recognized as compensation expense over the requisite service period (typically the vesting period). Answer C is correct. Intrinsic value (A, D) is only used in limited circumstances for liability-classified awards or as a practical expedient for nonpublic entities. Fair value on the exercise date (B) is not the measurement date for equity-classified awards.
- A company issues 1,000 shares of restricted stock (not RSUs) to an employee when the market price is $30 per share. The shares vest in 2 years. Under ASC 718, what amount is recorded as unearned compensation at grant?
Answer: $30,000 debit to Unearned Compensation (contra-equity) and $30,000 credit to Common Stock and APIC.
Under ASC 718 for restricted stock awards (not RSUs), the grant is recorded by debiting Unearned Compensation (a contra-equity account) and crediting Common Stock and APIC at the grant-date fair value: 1,000 x $30 = $30,000. The unearned compensation is then amortized to expense over the 2-year vesting period. Answer C is correct. Answer A defers all recognition incorrectly. Answer B recognizes the full amount immediately. Answer D records it as an asset (Prepaid Compensation), which is not the correct ASC 718 presentation - the debit is to contra-equity, not an asset.
- Under ASC 718, which of the following disclosures is required in the notes to the financial statements for stock-based compensation?
Answer: The weighted-average grant-date fair value of options granted during the period.
ASC 718 requires disclosure of the weighted-average grant-date fair value of options and similar instruments granted during the period, along with the method and significant assumptions used to estimate fair value. Answer B is correct. Individual employee names (A) are not disclosed. Per-grant model inputs (C) are reported in aggregate or weighted-average form, not individually. Projected future expense by employee (D) is not required - only aggregate unrecognized compensation cost and expected recognition period.
